The novel coronavirus (“COVID-19”) outbreak has sickened thousands of people around the world and caused incalculable health and economic damage. One way for impacted businesses, consumers, workers, homeowners, and others to seek relief is through legal action. Unfortunately, there are bad actors during times of crisis such as those that seek to profit or fail to satisfy their obligations and duties of care that could have otherwise helped stem the impact of the pandemic.
Axler Goldich can help those who have been impacted by the coronavirus. If you feel you have been wronged, let us know.
Nearly every state has enacted policies to close nonessential businesses and help slow the spread of COVID-19 in the United States. Business owners all around the country have been forced to close their doors for the foreseeable future. Business interruption insurance can cover lost income, mortgage payments, rent, loans, taxes, payroll, and other costs during times of crisis. However, many owners who paid premiums for years are now being told their business interruption insurance doesn’t cover coronavirus.
Axler Goldich is investigating denied Covid-19 business interruption insurance claims. If your business was ordered to close because of the virus and had its insurance claim denied, you might have a case.
Event operators or small to mid-size businesses including event sponsors, venue owners, promoters, merchandisers and others that bought event cancellation coverage insurance and were forced to cancel due to the coronavirus may have event cancellation insurance claims. Many entrepreneurs and business owners have suffered extensive losses due to the outbreak of novel coronavirus and forced business closures due to Covid-19. Axler Goldich is here to offer assistance in these trying times.
When making an event cancellation claim under your event cancellation insurance based on COVID-19-related cancellations, it is important to fully understand the conditions of coverage.
If you’ve been denied your claims or want advice about whether you have coverage for event losses, our attorneys are available for no-cost review and consultations at your convenience.
With customers panic buying, distribution networks stretched thin, and critical supplies experiencing increased demand, opportunists are unfortunately exploiting the coronavirus crisis for profit. According to an investigation by the Associated Press, there has been a surge in coronavirus-related price-gouging claims across the United States.
States are combatting price gouging, as such practices are often monitored when a state of emergency has been declared. Although state attorneys general have the authority to issue cease-and-desist letters to price gougers, investigate them, issue fines, and file lawsuits, and complaints can be made directly to state authorities, price-gouged coronavirus consumers can also take legal matters into their own hands.
If you were the victim of price gouging amid the coronavirus outbreak, let us know.
Shoppers are understandably stocking up on supplies that they believe help combat and protect against coronavirus. However, companies are incentivized to take advantage of this demand and hyping certain health benefits of their products. But state and federal laws prohibit companies from making false or misleading product claims. Those that make bogus health claims can face legal action from government authorities and private consumers.
If you have encountered products that claim to treat, prevent, or kill the coronavirus, let us know.
Many companies’ financial fates could be at stake due to the economic repercussions of coronavirus. But that doesn’t mean securities laws don’t still apply to them. As the pandemic moves forward, certain companies, such as those in the medical, telework, and delivery industries, may claim they are particularly well-positioned to weather the outbreak. But, if their products are defective or if they have overstated their ability to confront the pandemic, companies can be liable under securities laws.
Notably, one of the two COVID19-related securities class actions filed so far is premised on allegations that a company falsely “claim[ed] unequivocally that the company had successfully developed a vaccine against the spread of COVID-19 and that it anticipated rapidly bringing that vaccine to market.” Allegedly, once a third party exposed these claims as misstatements, calling for an SEC investigation into the “ludicrous and dangerous claim that they designed a [COVID-19] vaccine in 3 hours,” the company’s stock price plunged from its March 9 opening price of $19.36 per share to $5.70. Companies publicly stating they have developed products to combat the virus without factual support may be liable for a stock drop when the truth comes to light.
Contact us to report a possible coronavirus securities claim.
While we’re taking precautions to keep our employees and clients healthy, we continue to provide services efficiently and without interruption. Our attorneys are available to answer any questions or concerns you have about coronavirus litigation or other legal matters. Call us today at 866-207-2920 or 267-534-7400.